tween individual modules (parameters: method='hybrid' , minimum module size=25, deepSplit=2, PAM respects dendrogram=T). [5] This routine defines modules based on the shape of the dendrogram, and is more flexible than choosing a single cutoff value.
The outcome of this procedure was a separate series of modules (i.e. 'clusters' or 'groups') of coexpressed genes for each leukocyte subset. The module representing the transcriptional response to type 1 interferon (IFN-I ) was selected by comparison to the 21 gene IFN-I 'signature' (IFI27, IFI6, RSAD2, IFI44, IFI44L,  USP18, LY6E, OAS1, SIGLEC1, ISG15, IFIT1, OAS3, HERC5, MX1, LAMP3, EPSTI1, IFIT3, OAS2, RTP4,  PLSCR1 , SPATS2L) published in [6] . This signature was chosen for its specificity: it consists of genes upregulated in vitro after healthy PBMC were cultured with a range of IFN-I subtypes (10 IFN-α subtypes and IFN-β) that were also upregulated in the whole blood of SLE patients and that were neutralised by an anti-IFN-α monoclonal antibody.
Relationship of leukocyte subset-specific IFN-I modules to published IFN-I analyses.
A recent publication has reported three distinct clusters of IFN-I associated gene expression in whole blood, annotated as modules 1.2, 3.4 and 5.12. [7] Module 1.2 was noted to be most sensitive to IFN-I expression, being upregulated earlier and to a higher degree than the other modules, whereas genes in module 5.12 were only upregulated in the subset of patients possessing the strongest IFN-I signature. The authors presented some evidence that this may represent differing sensitivities of genes in each module to circulating interferon-β and interferon-γ. We wondered whether these patterns might also be explained by their expression within lymphoid and myeloid subsets of varying size.
First, we examined the overlap between genes in the published whole blood modules 1.2, 3.4 and 5.12 and the 67 core IFN-I genes belonging to IFN-I modules in all leukocyte subsets. Fifteen (68%) of genes in the whole blood module 1.2 were also members of this core IFN-I gene set, compared with 18 (42%) of genes in module 3.4 and 13 (28%) of genes in module 5.12. The differing proportions were statistically significant (χ2 = 9.8, p-value = 0.0075). We then examined the overlap between genes in the published whole blood modules 1.2, 3.4 and 5.12 and each individual leukocyte subset-specific IFN-I module. The module membership scores for overlapping genes are shown in figure S3 . For CD4+ and CD8+ T-cells in particular, we found that module membership scores for genes shared with module 1.2 were higher than those shared with modules 3.4 and 5.12. This suggests that genes in module 5.12 are more weakly associated with IFN-I in T-cells than those in module 1.2 and that this, combined with differing poportions of T-cells and myeloid cells, may represent an alternative explanation the different properties of the whole blood IFN-I associated modules 1.2, 3.4 and 5.12.
Supplementary Tables   Table S1 . Number of gene expression microarrays by diagnosis and leukocyte subset. 82 (60) 39 (59) 25 (89) 74 (58) 32 (54) 53 (93) 100 (58) 48 (62) 40 (93) 93 (58) 51 (60) Home centre Cambridge anti-Ro (%)
12 (44) 3 (23) 17 (49) 15 (52) anti-La (%) 8 (28) anti-RNP (%)
8 (30) 3 (23) 13 (37) 10 (34) anti-Sm (%) Figure S1 . Leukocyte subset-specific IFN-I module membership scores for genes in each of the three whole blood IFN-I modules described by Chiche et al [7] (annotated as modules 1.2, 3.4 and 5.12) that also overlap with leukocyte subset-specific IFN-I modules in this analysis. P-values (Kruskal-Wallis) are shown in each panel, testing for differences by module. Where differences are significant overall, significant pairwise differences (Wilcoxon test, with Holm correction) are shown above. * p<0.05, ** p<0.005, *** p<0.0005. 
